References

Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways

10.1016/s0161-5890(02)00101-3 · 2002 · External reference

The role of CD4+ T cell responses in antitumor immunity

10.1016/s0952-7915(98)80228-8 · 1998 · External reference

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

10.1016/s0952-7915(00)00197-7 · 2001 · External reference

The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28

10.1111/j.1600-065x.1998.tb01195.x · 1998 · External reference

The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides

10.1016/s0161-5890(02)00098-6 · 2002 · External reference

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

10.1038/onc.2008.273 · 2008 · External reference

Immune selective pressure and HLA class I antigen defects in malignant lesions

10.1007/s00262-006-0183-1 · 2007 · External reference

Analysis of HLA expression in human tumor tissues

10.1007/s00262-002-0332-0 · 2003 · External reference

HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications

10.3233/bd-2004-20112 · 2004 · External reference

Antigen-processing machinery breakdown and tumor growth

10.1016/s0167-5699(00)01692-3 · 2000 · External reference

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

10.1007/s00262-008-0515-4 · 2008 · External reference

Role of altered expression of HLA class I molecules in cancer progression

10.1007/978-0-387-72005-0_13 · 2007 · External reference

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying mechanisms

10.1111/j.1399-0039.2006.00777.x · 2007 · External reference

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

10.1016/s0167-5699(96)10075-x · 1997 · External reference

Downregulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

10.1097/01.ju.0000094807.95420.fe · 2004 · External reference

WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?

10.1007/s00401-007-0231-8 · 2007 · External reference

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

10.1016/0167-5699(95)80033-6 · 1995 · External reference

HLA class I antigen down-regulated in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker

10.1158/0008-5472.can-06-0488 · 2006 · External reference

Altered expression of HLA class I antigens in breast cancer: association with prognosis

10.1002/1097-0215(20001120)89:6<500::aid-ijc6>3.0.co;2-# · 2000 · External reference

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

10.1007/s00262-007-0362-8 · 2008 · External reference

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products

10.4049/jimmunol.137.7.2299 · 1986 · External reference

β2-Microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

10.4049/jimmunol.171.4.1918 · 2003 · External reference

Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies

10.1111/j.1399-0039.2005.00462.x · 2005 · External reference

Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate

10.1016/0022-1759(90)90458-8 · 1990 · External reference

Unresolved reference

1997 · External reference

Proteasomes are not a target for doxorubicin in feline injection-site sarcoma

10.1016/j.jcpa.2010.02.003 · 2010 · External reference

Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells

10.1634/stemcells.2007-0705 · 2008 · External reference

Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins

10.1016/s0960-9822(00)00174-3 · 1994 · External reference

Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions

2004 · External reference

Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis

10.1016/j.humpath.2003.06.001 · 2003 · External reference

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

10.1158/1078-0432.ccr-04-2146 · 2005 · External reference

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma

10.1158/0008-5472.can-06-4735 · 2007 · External reference

Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas

10.1007/s00262-009-0765-9 · 2010 · External reference

Multiple defects of the antigenprocessing machinery components in human neuroblastoma: immunotherapeutic implications

10.1038/sj.onc.1208594 · 2005 · External reference

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors

10.1158/1078-0432.ccr-04-2588 · 2005 · External reference

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

10.1007/s00262-009-0769-5 · 2010 · External reference